TAMs are negatively correlated with the survival of hepatocellular carcinoma (HCC) patients, since these TAMs secrete TGFβ1 to induce the EMT and confer higher invasiveness in cancer cells [91]. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.